Inspire Pharmaceuticals
Durham
About Inspire Pharmaceuticals
Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The advanced compounds in the clinical pipeline are denufosol tetrasodium for cystic fibrosis and Prolacria for dry eye, both of which are in Phase III development, and AzaSite for blepharitis, which is in Phase II development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Ticker: nasdaq:ISPH
- Website: inspirepharm.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/inspire-pharmaceuticals-610927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.